Dr. Rachna Shroff, M.D.
Claim this profileUniversity of Arizona Cancer Center
Studies Pancreatic Cancer
Studies Liver Cancer
15 reported clinical trials
33 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
metastatic
RECIST 1.1
2Liver Cancer
Stage IV
Stage III
MSI
Affiliated Hospitals
Clinical Trials Rachna Shroff, M.D. is currently running
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting4 awards Phase 318 criteria
Atezolizumab + Cabozantinib
for Pancreatic Cancer
Pancreatic cancer is one of the leading causes of cancer deaths in the United States with limited treatment options, especially for those patients with metastatic disease. Combination treatment with cabozantinib and atezolizumab, has demonstrated safety for the treatment of other cancers and has shown promise in preclinical studies utilizing patient derived pancreas organoids. In this study, patients with refractory, metastatic pancreatic cancer will receive combination cabozantinib + atezolizumab and the efficacy of this treatment will be assessed through overall response rate (ORR), disease control rate (DCR), median overall survival (mOS), and median progression free survival (mPFS). Safety and tolerability of combination cabozantinib plus atezolizumab in metastatic pancreatic cancer patients will also be assessed and immune profiling pre- and post-treatment will be explored.
Recruiting1 award Phase 212 criteria
More about Rachna Shroff, M.D.
Clinical Trial Related6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rachna Shroff, M.D. has experience with
- Gemcitabine
- Cisplatin
- Oxaliplatin
- LSTA1
- Cabozantinib
- Atezolizumab
Breakdown of trials Rachna Shroff, M.D. has run
Pancreatic Cancer
Liver Cancer
Bile Duct Cancer
Gallbladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rachna Shroff, M.D. specialize in?
Rachna Shroff, M.D. focuses on Pancreatic Cancer and Liver Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are metastatic.
Is Rachna Shroff, M.D. currently recruiting for clinical trials?
Yes, Rachna Shroff, M.D. is currently recruiting for 2 clinical trials in Tucson Arizona. If you're interested in participating, you should apply.
Are there any treatments that Rachna Shroff, M.D. has studied deeply?
Yes, Rachna Shroff, M.D. has studied treatments such as Gemcitabine, Cisplatin, Oxaliplatin.
What is the best way to schedule an appointment with Rachna Shroff, M.D.?
Apply for one of the trials that Rachna Shroff, M.D. is conducting.
What is the office address of Rachna Shroff, M.D.?
The office of Rachna Shroff, M.D. is located at: University of Arizona Cancer Center, Tucson, Arizona 85724 United States. This is the address for their practice at the University of Arizona Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.